Balyasny Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 2514 |
|
|
2024
Q4 | – | Sell |
-96,154
| Closed | -$499K | – | 2481 |
|
|
2024
Q3 | $499K | Buy |
+96,154
| New | +$499K | ﹤0.01% | 1538 |
|
|
2024
Q1 | – | Sell |
-362,760
| Closed | -$3.19M | – | 2513 |
|
|
2023
Q4 | $3.19M | Sell |
362,760
-107,089
| -23% | -$941K | 0.01% | 911 |
|
|
2023
Q3 | $5.39M | Buy |
+469,849
| New | +$5.39M | 0.01% | 764 |
|
|
2018
Q4 | – | Sell |
-8,262
| Closed | -$205K | – | 1630 |
|
|
2018
Q3 | $205K | Sell |
8,262
-3,106
| -27% | -$77.1K | ﹤0.01% | 1362 |
|
|
2018
Q2 | $312K | Buy |
+11,368
| New | +$312K | ﹤0.01% | 1325 |
|
|
2016
Q1 | – | Sell |
-7,630
| Closed | -$261K | – | 1356 |
|
|
2015
Q4 | $261K | Sell |
7,630
-4,120
| -35% | -$141K | ﹤0.01% | 875 |
|
|
2015
Q3 | $350K | Buy |
+11,750
| New | +$350K | ﹤0.01% | 712 |
|
|
2015
Q2 | – | Sell |
-80,323
| Closed | -$1.67M | – | 1125 |
|
|
2015
Q1 | $1.67M | Buy |
+80,323
| New | +$1.67M | 0.01% | 450 |
|